Heart Attack

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.Clopidogrel, currently sold…

1 day ago

The Holy Grail of Cardiology Has Arrived

Peer-Reviewed Paper Confirms Cavadex Drives Plummeting Coronary Artery Calcium Scores : Reversing the Irreversible ROBINA AND QUEENSLAND, AUSTRALIA / ACCESS…

1 week ago

AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first…

2 weeks ago

WearOptimo Strengthens Intellectual Property Portfolio with Issuance of Additional Patents to Support Wearable Sensor Technology for Health Monitoring

BRISBANE, Australia and NEW YORK, Jan. 9, 2026 /PRNewswire/ -- WearOptimo, a healthcare technology company developing next-generation Microwearable sensors for hydration and…

3 weeks ago

The Assistance Fund Opens New Program for Myeloproliferative Neoplasms

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Myeloproliferative Neoplasms ORLANDO, FLORIDA / ACCESS Newswire…

3 weeks ago

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial ESTERO, FL…

3 weeks ago

Life Line Screening (Updated): What You Need to Know?

New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- in 2026, The greatest way to stay healthy and avoid illnesses…

4 weeks ago

Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering

CHATHAM, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated…

1 month ago

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect…

1 month ago

How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ

Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details – Best Weight Loss Supplement Phenq…

1 month ago